Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

China · Delayed Price · Currency is CNY

17.92

+0.19 (1.07%)

Apr 30, 2026, 2:55 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Biopharmaceutical		80.80M	134.59M	318.49M	392.27M	589.10M
Biopharmaceutical Growth		-39.96%	-57.74%	-18.81%	-33.41%	777.27%
Total		80.80M	134.59M	318.49M	392.27M	589.10M
Total Growth		-39.96%	-57.74%	-18.81%	-33.41%	777.27%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China		80.80M	134.59M	318.49M	392.27M	589.10M
China Growth		-39.96%	-57.74%	-18.81%	-33.41%	777.27%
Total		80.80M	134.59M	318.49M	392.27M	589.10M
Total Growth		-39.96%	-57.74%	-18.81%	-33.41%	777.27%

Source: S&P Global Market Intelligence.